Current approaches and challenges to cervical cancer prevention
DOI:
https://doi.org/10.52340/healthecosoc.2023.07.02.14Keywords:
human papilloma virus, prevention, cervical cancerAbstract
Introduction: Cervical cancer is recognized as a global problem due to its increasing prevalence. Countries are trying to introduce preventive measures to reduce the mortality of women. The aim of the paper is to analyze the cervical cancer prevention strategies of the healthcare systems of different countries. Methodology: a systematic literature search was conducted using databases of scientific-refereed journals (Science Direct, Google Scholar, DOAJ, PubMed). Results: The study identified promising approaches to cervical cancer screening and prevention that could further strengthen the effectiveness of existing WHO strategies and national health systems. Conclusion: it is necessary to develop powerful educational campaigns by the state using mass media and social networks, which will help to increase the screening rate, as well as to raise the awareness of adolescents and their parents about the benefits of vaccination against human papilloma virus (HPV).
References
ოსიშვილი მ. (2023). მოსახლეობის ინფორმირებულობა ონკოლოგიური დაავადებების ადრეული გამოვლენის თაობაზე. ჯანდაცვის პოლიტიკა, ეკონომიკა და სოციოლოგია, 7(2).
გაჩეჩილაძე ქ, განუგრავა ნ. (2023). ონკოლოგიური დაავადებების შესახებ საზოგადოების ინფორმირებულობის შეფასება საქართველოში. ჯანდაცვის პოლიტიკა, ეკონომიკა და სოციოლოგია, 7(2).
PAP ტესტზე დაფუძნებული საშვილოსნოს ყელის კიბოს სკრინინგი და დიაგნოსტიკა (გაიდლაინი)( 2022 წ) https://moh.gov.ge/ka/guidelines/
საშვილოსნოს ყელის კიბოს სკრინინგისა და პროფილაქტიკის ძირითადი ასპექტები (2022) UNFPA საქართველო. https://georgia.unfpa.org/ka
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F. (2020). Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health, 8(2), e191-e203.
Burger EA, Smith MA, Killen J, Sy S, Simms KT, Canfell K, Kim JJ. (2020). Projected time to elimination of cervical cancer in the USA: a comparative modeling study. The Lancet. Public health, 5(4), e213–e222. https://doi.org/10.1016/S2468-2667(20)30006-2
Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, … Hutubessy R. (2020). Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modeling analysis in 78 low-income and lower-middle-income countries. Lancet (London, England), 395(10224), 591–603.
Demirtas B, Acikgoz I. (2013). Promoting attendance at cervical cancer screening: understanding the relationship with Turkish womens' health beliefs. Asian Pacific journal of cancer prevention: APJCP, 14(1), 333–340.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Soerjamataram I, Bray F. (2018). Global cancer Observatory: cancer today. Lyon, France: international agency for research on cancer.
Gunes AC, Ozgul N, Turkyılmaz M, Kara F, Unlu F, Ayhan A, Gultekin M. (2023). Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program. Cancer medicine, 10.1002/cam4.6740. Advance online publication.
HPV Vaccine. (2023, 16.08). Centers for disease control and prevention. https://www.cdc.gov/hpv/parents/vaccine-for-hpv.html
International Agency for Research on Cancer. (2021). IARC handbooks of cancer prevention: cervical cancer screening, Vol. 18. International agency for research on cancer, WHO. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Cervical-Cancer-Screening-2022
Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, Kim J, Poljak M, Nieminen P, Sasieni P, Kesic V, Cuzick J, Gultekin M. (2020). Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). British journal of cancer, 123(4), 510–517.
Le Bihan-Benjamin C, Audiger C, Khati I, de Bels F, Jean Bousquet P, Barré S. (2023). Cervical cancer screening pathways in France in 2015-2021, a nationwide study based on medico-administrative data. Preventive medicine reports, 36, 102429.
Lemp JM, De Neve JW, Bussmann H, Chen S, Manne-Goehler J, Theilmann M, ... Geldsetzer P. (2020). Lifetime prevalence of cervical cancer screening in 55 low-and middle-income countries. Jama, 324(15), 1532-1542.
Lönnberg S, Anttila A, Luostarinen T, Nieminen P. (2012). Age-specific effectiveness of the Finnish cervical cancer screening programme. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21(8), 1354–1361.
Neis F, Holleczek B, Henes M, Juhasz-Böss I, Wallwiener D, Neis KJ. (2023). Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany. Archives of gynecology and obstetrics, 307(4), 1125–1136.
Pankakoski M, Anttila A, Sarkeala T, Heinävaara S. (2019). Effectiveness of cervical cancer screening at age 65 - A register-based cohort study. PloS one, 14(3), e0214486.
Rachlin A, Danovaro-Holliday MC, Murphy P, Sodha SV, Wallace AS. (2022). Routine vaccination coverage—worldwide, 2021. Morbidity and Mortality Weekly Report, 71(44), 1396.
Sankaranarayanan, R. (2014). Screening for cancer in low-and middle-income countries. Annals of global health, 80(5), 412-417.
Shankar A, Roy S, Rath GK, Kamal VK, Kharade V, Sandeep K. (2017). Carcinoma uterine cervix: Evolving trends and Impact of national cancer control Program in India. Ind J Soc Prev Rehab Onc, 1(1), 16-22.
Singh GK, Azuine RE, Siahpush M. (2012). Global inequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development. International Journal of MCH and AIDS, 1(1), 17.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians, 71(3), 209–249.
World Health Organization. (2020). Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization.
World Health Organization. (2022). One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer. Geneva: World Health Organization.
U.S. Preventive Services Task Force. Cervical Cancer Screening. 2018. Retrieved from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
Zhang M, Zhong Y, Wang L, Bao H, Huang Z, Zhao Z, Zhang X, Li C, Sun KL, Wu J, Zheng X, Wang L. (2022). Cervical Cancer Screening Coverage - China, 2018-2019. China CDC weekly, 4(48), 1077–1082.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
